Sfoglia per Soggetto "disease marker"
Items 21-30 di 30
-
Language performance: An indicative marker for subtle changes in MCI subtypes
(2017)This study aims at investigating morhpo-syntactic variables perception by MCI subtypes patients beyond memory impairment. Novel language tasks have been introduced and conducted in a computerized environment in order to ... -
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: Results from the BIOSIGNAL study
(2021)Aims: Lipoprotein(a) [Lp(a)] is a recognized causal risk factor for atherosclerotic cardiovascular disease but its role for acute ischaemic stroke (AIS) is controversial. In this study, we evaluated the association of Lp(a) ... -
Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: Results of a 3-year prospective donor study (1995-1997)
(2003)Background: The risk of infection with transfusion-transmitted viruses has been reduced remarkably. A zero-risk blood supply, however, remains a popular goal. A 3-year prospective donor study was conducted in the Epirus ... -
The neurobiology of dementia: Spatial and temporal dynamics of Alzheimer's disease major biomarkers
(2017)Dementia, with most prevailing cause Alzheimer's disease (AD), is a condition characterized by memory loss and decline of other cognitive functions, of particular severity to affect one's routine. AD illustrates as an array ... -
The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis
(2016)Objective: Growth hormone (GH) and insulin-like growth factor I (IGF-I) are the principal biomarkers used to assess disease activity in acromegaly, and any discrepancy between them renders interpretation of results ... -
Plasmir: A manual collection of circulating micrornas of prognostic and diagnostic value
(2021)Only recently, microRNAs (miRNAs) were found to exist in traceable and distinctive amounts in the human circulatory system, bringing forth the intriguing possibility of using them as minimally invasive biomarkers. miRNAs ... -
A Prospective Validation of the Updated Movement Disorders Society Research Criteria for Prodromal Parkinson's Disease
(2020)Objective: The objective of this study was to validate the recently updated research criteria for prodromal Parkinson's disease (pPD) proposed by the International Parkinson's Disease and Movement Disorders Society. Methods: ... -
Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta
(2014)Background & Aims: Immunohistochemical assessment of liver tissue in chronic delta hepatitis (CDH) is underinvestigated. Aim of the study was (i) to assess variables associated with hepatitis D antigen (HDAg), hepatitis B ... -
Serum laminin and collagen IV in inflammatory bowel disease
(2003)Background/Aims: Laminin and collagen IV have been proposed as extracellular matrix serum markers. Because fibrosis is a major complication of inflammatory bowel disease, serum concentrations of laminin and collagen IV ... -
Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD
(2017)Background Extracellular matrix (ECM) remodeling of the lung tissue releases protein fragments into the blood, where they may be detected as serologic surrogate markers of disease activity in COPD. Our goal was to assess ...